Edoxaban Dosing Regimens Evaluated for AF-Related Stroke
The comprehensive net clinical outcomes of low- and high-dose edoxaban was evaluated for stroke in atrial fibrillation.
Arrhythmia
Atrial Fibrillation Burden at 6 Months Better Predictor Than 30-Second Atrial Fibrillation Recurrence
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
Medicare Claims Database Useful for Detecting Arrhythmogenic Risk of QT-Prolonging Drugs
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
Comparative Effectiveness of Anticoagulants for Valvular AF
Risks for ischemic stroke or systemic embolism, major bleeding events lower with DOACs overall as a class versus warfarin.
A Closer Look at Dual vs Triple Therapy After PCI in Atrial Fibrillation
Dual antithrombotic therapy is now the ‘default’ regimen, with triple therapy reserved for patients who may benefit it after carefully assessing risk-benefit ratio.
Linear Increase in AF Incidence With Alcohol Consumption Even at Low Doses
This European study evaluated the relationship between alcohol consumption, cardiac biomarkers, and incident atrial fibrillation across the spectrum of alcohol intake.
SGLT2 Inhibitor Use Linked to Reduced Atrial Arrhythmia Risk in T2DM
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
Remote PAP Monitoring by Implanted Sensor May Improve HF Management
Remote PAP-guided management better reduced PAP, hospitalizations, and mortality among patients with NYHA Class III HF.
Renal Dysfunction, Lower Body Weight May Increase DOAC-Associated Bleeding Risk in AF
The authors reported that 25 of the total 233 patients included in the study experienced a bleeding event.
Deep Neural Networks Using 12-Lead ECG Predicts New-Onset AF
Deep neural networks using information from a12-lead ECG can predict new-onset atrial fibrillation (AF) risk in patients with no prior history of AF.
-
Loading...
-
Loading...
Next post in Arrhythmia
